Medicine and Dentistry
Abacavir
100%
Highly Active Antiretroviral Therapy
69%
Woman
53%
Human Immunodeficiency Virus
46%
Interleukin 6
38%
Cohort Analysis
38%
Enalapril Maleate
38%
D-Dimer
38%
Biological Marker
30%
C Reactive Protein
30%
Association
23%
Man
23%
Serositis
15%
RNA
15%
Plasma
15%
Cardiovascular Disease
7%
Antiretroviral Therapy
7%
Person
7%
Experience
7%
Marker
7%
INIS
levels
61%
women
53%
hiv
46%
reduction
38%
interleukins
38%
dimers
38%
sensitivity
30%
biological markers
30%
AIDS
30%
c-reactive protein
30%
men
23%
inflammation
23%
rna
15%
plasma
15%
design
7%
cardiovascular diseases
7%
therapy
7%
comparative evaluations
7%
control
7%
kidneys
7%
randomness
7%
elevation
7%
Biochemistry, Genetics and Molecular Biology
Abacavir
100%
Human Immunodeficiency Virus
46%
Interleukin 6
38%
D-Dimer
38%
Reduction (Chemistry)
38%
Cohort Study
38%
C-Reactive Protein
30%
Association
23%
Case-Control Study
23%
Experience
7%
Pharmacology, Toxicology and Pharmaceutical Science
Abacavir
100%
HIV
46%
Enalapril Maleate
38%
D Dimer
38%
Interleukin 6
38%
Biological Marker
30%
C Reactive Protein
30%
RNA
15%
Random Effects Model
15%
Neuroscience
Abacavir
100%
HIV
46%
Interleukin 6
38%
D Dimer
38%
C-Reactive Protein
30%
RNA
15%
Immunology and Microbiology
Human Immunodeficiency Virus
46%
Interleukin 6
38%
Reduction (Chemistry)
38%
C-Reactive Protein
30%
Association
23%
Systemic Inflammation
15%
Blood Plasma
15%
Experience
7%